Skip to main content
. 2019 Oct;7(20):539. doi: 10.21037/atm.2019.10.07

Figure 6.

Figure 6

ES suppress the growth of tumor xenografts in vivo. (A,B) Image of human lung cancer xenograft from the control group and ES-treated groups; (C) tumor weight of the three groups; (D,E) tumor volume and body weight were measured every three days. All data are expressed as mean ± SD. **, P<0.01; ***, P<0.001 compared to the control group. ES, Ecliptasaponin A.